Impact of stewardship pharmacist driven MRSA nasal surveillance and de-escalation of anti-MRSA therapy (STEW PHARM MRSA NASAL SURVEILLANCE)
Jessica Dillon, Domenic Vita, Jessica Abrantes-Figueiredo, Dora Wiskirchen · 2024
Read Impact of stewardship pharmacist driven MRSA nasal surveillance and de-escalation of anti-MRSA therapy (STEW PHARM MRSA NASAL SURVEILLANCE) by Jessica Dillon, Domenic Vita, Jessica Abrantes-Figueiredo, Dora Wiskirchen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11696584.txt.
Description
Jessica Dillon and co-authors evaluate a pharmacist driven nasal surveillance program in a 2024 study. The program aimed to cut unneeded vancomycin use in pneumonia patients. A nasal swab test for resistant staph can show when the drug is not needed. A stewardship pharmacist reviewed admitted patients on the drug, requested missing swabs, and advised stopping the drug after negative results.
Swab ordering jumped from about thirty six percent before the program to about eighty four percent with it. Appropriate stopping of the drug after a negative swab tripled, reaching about sixty one percent. The comparison covered a four week control period at a large teaching hospital. Readers see a pharmacist's daily review change prescribing habits measurably.
Catalog record
| CREATOR | Jessica Dillon, Domenic Vita, Jessica Abrantes-Figueiredo, Dora Wiskirchen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |